Ameritrade restricts trading of BIEL and HTDS
Now, it is customary for brokeragers to periodically place a restriction on web trading, forcing you to call in and speak with a live broker to place an order for you in cases when a stock experiences a sudden and drastic change in volume, price or both, but not to place a ban on buy orders without an explanation.
When I spoke to the Ameritrade representatives more than once and asked them about the reason, they gave me only speculative reasons, but nothing definitive. “It could be to prevent fraud, or…” said the representative before I suddenly interrupted him. I asked him if he knew for fact that was taking place, but he did not confirm. I had to scold him for saying something like that because, in my opinion, Ameritrade could be participatory in fraud itself.
@@CalendarRight@@This could be classified as a consipracy theory but again, it is just that, a theory. Shany and questionable actions on parts of brokerages and market makers aren’t all that uncommon. By preventing clients to buy and forcing them to sell, Ameritrade is essentially dowing the following two critical things: 1. FORCE traders TO only SELL, not buy, which results in the price being driven DOWN, considering Ameritrade to be such a large holder of clients accounts. 2. RAISE undue SUSPICION in the stock, which makes people afraid that something COULD be going on, which creates a false impression of fraud, which leads people to sell, driving the price down to enable Ameritrade to naked short sell the stock.
Now, aside from that, I have found that BIEL and HTDS are both experiencing below average trading, significantly, with the price being so low. The reasons above explain why trading is so low, because account holders simply don’t want to sell. They just want to buy but they cannot. Could Ameritrade be involved in questionable naked short selling, or any sort of manipulation in stocks? There were 21 such stocks being placed on the same, no-buy, restriction without any further explanation. eTrade and Scottrade reported no such restrictions. Could Ameritrade be trying to manipulate these stocks and many other stocks?
The answer is: I do not know for sure, but I know that this left a very bad taste in my mouth that I am considering transferring at least half of my holdings with them to other brokerages where I do not experience such unexplained trouble. But one has to wonder if BIEL and HTDS recent dramatic drop in price is genuine or artificial. Both stocks have a huge potential. Both have genuine medical products to provide. BIEL, in particular, is even planning on expanding its market base for its award-winning anti-inflammatory patch in more markets, yet, we only see a drop in price with no good reason.
Contact Ameritrade and ask Ameritrade to explain the reasons for its restrictions, and you will get none.

By Nour Douchi on 12/14/2009 10:37 am PST -- Biotech